IIA
FBRX icon

IPG Investment Advisors’s Forte Biosciences FBRX Stock Holding History

IPG Investment Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-53
Closed -$24.4K – 137
2020
Q1 		$24.4K Hold
53
– – 0.01% 123
2019
Q4 		$10.7K Hold
53
– – ﹤0.01% 133
2019
Q3 		$13.2K Hold
53
– – ﹤0.01% 132
2019
Q2 		$134K Buy
+53
New +$157K 0.05% 138

Other funds holding FBRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IPG Investment Advisors's FBRX Position: Q2 2020 in Review

IPG Investment Advisors sold out of Forte Biosciences (FBRX) in Q2 2020, closing a stake of 53 shares — an estimated $24.4K sold.

IPG Investment Advisors first reported a position in FBRX in Q2 2019 and held it in 4 quarters. The position peaked at $134K in Q2 2019. 27 funds tracked by Wall St. Rank hold FBRX as of Q2 2020.

  • IPG Investment Advisors reported no remaining Forte Biosciences position as of Q2 2020 after selling out during the quarter.
  • IPG Investment Advisors sold 53 Forte Biosciences shares in Q2 2020, an estimated $24.4K.
  • IPG Investment Advisors first reported a position in Forte Biosciences in Q2 2019 and held it in 4 quarters.
  • IPG Investment Advisors's Forte Biosciences position peaked at $134K in Q2 2019.
  • 27 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2020.

Based on IPG Investment Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.